Abbott Next Generation Drug Eluting Stent 48mm Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

Also called NCT04282148

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 107 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04282148
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04282148. Allocation not applicable; no masking; primary purpose treatment. Start 2020-06-17 (actual); primary completion 2022-10-05 (actual). Results posted on 2024-02-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Abbott Next Generation Drug Eluting Stent 48mm Study
Acronym
SPIRIT 48
Intervention (Device)
ABT NG DES 48 EECSS
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct04282148
Content hash
18e992a2c728ea6869b73d47ef995c53f506516ef0cecb33e747eb0872709dfa